Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Cyclophosphamide 165fludarabine phosphate 110Peripheral Blood Stem Cell Transplantation 94Mycophenolic Acid 88Whole-Body Irradiation 81Etoposide 81Tacrolimus 73Busulfan 68Melphalan 67Filgrastim 66fludarabine 62Radiotherapy 56Doxorubicin 54Cyclosporine 54Rituximab 50Brentuximab Vedotin 48Antilymphocyte Serum 47Granulocyte Colony-Stimulating Factor 42Vinblastine 41Methotrexate 38Dacarbazine 37Cytarabine 35Gemcitabine 34Nivolumab 30Bleomycin 29Carmustine 28Vincristine 25Prednisone 25Sirolimus 24Bendamustine Hydrochloride 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hodgkin Disease × fialuridine × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡